ClinicalTrials.Veeva

Menu

Autonomic Cardiovascular Control in Response to Blood Volume Reduction in Blood Donors

H

Hvidovre University Hospital

Status

Completed

Conditions

Autonomic Imbalance
Blood Loss
Autonomic Dysfunction

Treatments

Device: Monitoring of the autonomic nervous system

Study type

Observational

Funder types

Other

Identifiers

NCT04499664
H-19069845

Details and patient eligibility

About

The function of the autonomic nervous system can be assessed using baroreflex sensitivity (BRS) and heart rate variability (HRV). Decreased HRV has been shown to be predictive of morbidity and mortality in diverse medical conditions such as acute myocardial infarction, aneurysmal subarachnoid haemorrhage, autoimmune diseases, sepsis and surgery.

The function of the autonomic nervous system has not yet been investigated in a "pure hypovolemia" model. The aim of the current study is therefore to investigate and describe the function of the autonomic nervous system prior to, during and after reduction of blood volume in healthy blood donors.

Enrollment

25 patients

Sex

Male

Ages

30 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Volonteers eligable for blood donation following the Danish legislation
  • Male
  • Age 30-45
  • Written informed consent
  • Speak and understand Danish

Exclusion criteria

Volonteers not eligable for blood donation following the Danish legislation, among others due to:

  • Alcohol and drug abuse
  • Cognitive dysfunction
  • Use of anxiolytic or antipsychotic drugs
  • Arrhythmias or heart failure
  • Diabetes mellitus type I
  • Diabetes mellitus type II
  • Use of opioids
  • History of following diseases in the autonomic nervous system: Parkinson disease, multiple sclerosis, autonomic neuropathies
  • History of cerebral apoplexy or transitory cerebral ischemia
  • Dementia
  • American Society of Anesthesiologists (ASA) score ≥ 4

Furthermore:

  • History of orthostatic intolerance and/or orthostatic hypotension
  • Use of following vasodilator antihypertensive drugs: beta-blockers, angiotensin converting enzyme inhibitors (ACEI), angiotensin 2 receptor blockers (ARBs), calcium channel blockers
  • Use of loop diuretics, thiazid diuretics and potassium-sparing diuretics

Trial design

25 participants in 1 patient group

Blood donors
Description:
Healhy young male bloddonors, aged 30-45
Treatment:
Device: Monitoring of the autonomic nervous system

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems